Hematologic Oncology Update cover image

Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series

Hematologic Oncology Update

00:00

Is There a Role to Combine Lenalidomide With Darratumumab?

Darratumab is a very reasonable treatment approach in this patient, says Dr. Warren Brenner. If they finish their stipulated cycles of the Darratumab, your question on maintenance again goes to what their risk factors are from a genetic standpoint. Revlimid maintenance with Darrumab for up to two years at least, and Bortesumab every other week as maintenance.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app